Filtered By:
Management: Venture Capital

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
Funds will allow Medcura to expand its commercial footprint and support IDE submission for a new class of surgical hemostat RIVERDALE, Md., Aug. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Medcura, Inc., a commercial-stage medical device comp... Devices, Surgery, Venture Capital Medcura, LifeGel, LifeFoam, hemostasis
Source: HSMN NewsFeed - August 12, 2021 Category: Pharmaceuticals Source Type: news

Start-up pitches high-tech glue for surgical leaks
TEL AVIV — An Israeli medical-device start-up is tackling one of the most dangerous occurrences in surgery — and it's doing it with glue.LifeSeal is a glue-like substance that augments and, in some surgeries like hernias, replaces the traditional and painful sealing procedures of staples, tacks and sutures.The privately-owned Israeli company behind the high-tech glue, LifeBond, says it should help in the treatment of post-operative leaks in closures of gastrointestinal and other surgical wounds. Patients get back up to speed more quickly and are more comfortable as they do.Orahn Preiss-Bloom, one of LifeBond's co-found...
Source: Medical Hemostat - November 16, 2014 Category: Technology Consultants Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs